Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Return on Assets (2024 - 2025)

Historic Return on Assets for NewAmsterdam Pharma (NAMS) over the last 2 years, with Q3 2025 value amounting to 0.28%.

  • NewAmsterdam Pharma's Return on Assets rose 1700.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.4% for FY2024, which is 300.0% up from last year.
  • Latest data reveals that NewAmsterdam Pharma reported Return on Assets of 0.28% as of Q3 2025, which was up 1700.0% from 0.2% recorded in Q2 2025.
  • In the past 5 years, NewAmsterdam Pharma's Return on Assets registered a high of 0.2% during Q2 2025, and its lowest value of 0.49% during Q2 2024.